Bang Nanobiotech

We seek to improve people's health & life quality
through innovation, because we care.

Bang Nanobiotech s.r.l is a startup founded in 2020.

To avoid side effects and pains from oral administration & injections, based on the 1st-time research breakthrough in last 30 years, we’ve developed an innovative dressing hydrogel BanGel, a versatile transdermal drug delivery platform, which can broadly expand the possibility of transdermal drug categories, solve all the limitations of other transdermal solutions, and maximize the value of transdermal drug delivery, providing for the patients an easy, smart, and efficient therapy!

Yunsong Yan

Co-Founder, CEO&CTO

Ph.D Dr.Yan has been the Chief Executive Officer and Chief Technical Officer since its foundation in 2020. His role on the team consists of commercial management, general administration, and R&D.

Xueting Bai

Co-Founder, CTO

Ph.D Dr.Bai has been the Chief Technical Officer since its foundation in 2020. Her role on the team consists of R&D product development in pharmacology, especially for the product in preclinical and clinical research.

Leonardo Qiu

Co-Founder, COO

Mr. Qiu mainly focuses on the day-to-day operations and investor relationship management in Bang Nanobiotech s.r.l.

Linru Cai

Co-Founder, CMO

Mrs Cai is one of the co-founders and is currently the Chief Marketing Officer of Bang Nanobiotech s.r.l.

Sheng Xu

Co-Founder, CSO

Mr. Xu is responsible for the corporate strategy definition & implementation, and overall organizational & governance process design and implementation in Bang Nanobiotech.

Shu Jiang


Miss Jiang is the Chief Financial Officer of Bang Nanobiotech s.r.l.

Yingjie Chu

IR Director

Mrs. Chu mainly focuses on the work of investor relations management & coordination in Bang Nanobiotech.

  • Mark Chen

  • Abraham Maldonado

  • Sep 27, 2022

Our startup has been selected for the next phase of the BIND 4.0 Open Innovation & Acceleration program Selection process.

  • Oct 1, 2021

Bang Nanobiotech developed an innovative dressing material in Wound Care, which is the first-time breakthrough in the past 30 years and gives a life-changing experience to patients.

​​​​​​​​We welcome inquiries from potential new investors and partners as we raise funds to support the development and commercialization of processes and products. Currently, Bang Nanobiotech s.r.l.’s funding is from business angels and private investors, as well as the EU’s research and innovation program.
A robust business plan and promising projections underpin an exciting financial opportunity to work with us in the launching stages. Our phased plan offers the potential for a high return on investment. The board of directors, leading advisory team, partners and investors are highly respected in field of respective materials and venture capital industries. With the help of passionate support, advice, and guidance from them, Bang Nanobiotech s.r.l becomes a promising company owning several patented biomedical products and nanotechnologies. These patents further underscore the terrific potential of our technology in changing the face of the biomedical materials market.
  1. Yunsong Yan, Tommaso Santaniello, Luca Bettini,Chloé Minnai, Andrea Bellacicca, Riccardo Porotti, Gabriele Faraone, Cristina Lenardi and Paolo Milani. Electroactive Ionic Soft Actuators with Monolithically Integrated Gold Nanocomposite Electrodes. Accepted byAdv.Mater. 2017.DOI: 10.1002/adma.201606109.
  2. Tommaso Santaniello, Lorenzo Migliorini, Erica Locatelli, Ilaria Monaco,Yunsong Yan, Cristina Lenardi, Mauro Comes Franchini and Paolo Milani. Hybrid nanocomposites based on electroactive hydrogels and cellulose nanocrystals for high-sensitivity electro-mechanical underwater actuation. Smart Materials and Structures, 2017, 26 26(8):085030.
  3. Tommaso Santaniello*, Yunsong Yan. Electroactive Soft Actuators Based on Ionic Gel/Gold Nanocomposites Produced by Supersonic Cluster Beam Implantation. DOI10.13140/RG.2.2.26638.05448 (Conference: Spring Meeting 2017 -eMRSAt: Strasbourg (FR)).
  4. Tommaso Santaniello, Yunsong Yan, Alessandro Tocchio, Federico Martello, Federico Gassa, Patrick Webb, Weiwei Zhao, Margherita Tamplenizza, Carsten Schulte, Yang Liu, David Hutt, Paolo Milani, Paul Conwayand Cristina Lenardi. On-Chip Single Cell Funneling Operated by Microfabricated Thermo-Responsive Hydrogel Layers. J. Micromech. Microeng, 2015, 25, 075004.
  5. Tommaso Santaniello*, Yunsong Yan*, Alessandro Tocchio, Federico Martello, Paolo Milani, Cristina Lenardi. A Room-Temperature Bonding Technique for the Packaging of Hydrogel-Based Hybrid Microfluidic Devices. Microfluid. Nanofluid, 2015, 19, 31-41. (*Equal first author)
  6. Lorenzo Migliorini*, Tommaso Santaniello*, Yunsong Yan*, Cristina Lenardi, Paolo Milani. Low-Voltage Electrically Driven Homeostatic Hydrogel-Based Actuators for Underwater Soft Robotics.Sens. Actuators. B. Chem, 2016, 228, 758-766.(*Equal first author)
  7. Yunsong Yan, Jiayan Li, Jinhong Zheng, Ying Pan, Jinzhi Wang, Xiaoying He, Lumian Zhang, Daojun Liu. Poly(L-lysine)-Based Star-Block Copolymers as pH-Responsive Nanocarriers for anionic drugs. Colloids and SurfacesB: Biointerfaces,2012, 95, 137-143.
  8. Yunsong Yan, Daixu Wei, Jiayan Li, Jinhong Zheng, Ganggang Shi, Wenhong Luo, Ying Pan, Jinzhi Wang, Lumian Zhang, Xiaoying He, Daojun Liu. A Poly(L-lysine)-Based Hydrophilic Star-Block Copolymer as a Protein Nanocarrier with Facile Encapsulation and pH-Responsive Release. Acta Biomater, 2012, 8(6), 2113-2120.
  9. Yunsong Yan,Lihui Liao, Daojun Liu. Poly (L-glutamic acid)-based star-block copolymers as pH-responsive release systems. Journal of Controlled Release,2011, 158S1, e60-e61. (Conference Abstracts).
  10. Qinrong Wang, Jun Yu, Yunsong Yan, Shaoqiang Xu,Fangfang Wang, Qingnan Li, Jinzhi Wang, Xin Zhang and Daojun Liu. Controlled Biomimetic Silica Formation using Star-Shaped Poly(L-lysine). Polym. Chem, 2012, 3, 1284-1290.
  11. Xueting Bai, Peixuan Yang, Qiaoling Zhou, Bozhi Cai, Manon Buist-Homan , He Cheng, Jiyang Jiang, , Xiajiong Luo, Klaas Nico Faber, Han Moshage, Ganggang Shi. The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro. Br J Pharmacol 2017; 174:41-56.
  12. Bai, Xueting; Chen, Yicun; Li, Mingcai; Buist-Homan, Manon; Shi, Ganggang; Moshage, Han; Faber, Klaas Nico. Purified compounds from the Chinese herb Ipomoea stolonifera have anti-inflammatory and cytoprotective effects on rat hepatocytes. Hepatology, Vol. 56, 10.2012, p. 548A-548A.
  13. Bai, X, Yang, P, Zhou, Q, Cai, B, Buist-Homan, M, Zheng, H, Jiang, J, Luo, X, Faber, KN, Shi, G & Moshage, H, 'The natural compound hesperetin protects against fulminant hepatitis in vivo and in vitro in mice' Hepatology, vol 63, 10.2016 no. 1 SUPP, 639, pp. 318A-318A.
  14. Xueting Bai, Yicun Chen, Weizhou Chen, Huaping Lei, Fenfei Gao, Yongjie Qin, Jiaojiao Zheng, Ganggang Shi. The effect of black coral extraction on acute lung inflammation induced by cigarette smoke in mice. Exp Lung Res. 2011 Dec; 37(10): 627-632.
  15. Xueting Bai, Yicun Chen, Weizhou Chen, Huaping Lei, Ganggang Shi. Volatile Constituents, Inorganic Elements and Primary Screening of Bioactivity of Black Coral Cigarette Holders. Mar. Drugs. 2011; 9: 863-878.
  • Viale Ortles, 22/4, 20139, Milano, MI, Italia